ENSC Improves Position
ENSC Stock | USD 6.58 0.27 3.94% |
About 58% of Ensysce Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ensysce Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ensysce Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ensysce Biosciences stock news signals to limit their universe of possible portfolio assets.
Ensysce |
By Brad Sorensen, CFA NASDAQENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences released its 3Q2024 results that showed a much improved cash balance of 4.2 million due in large part to the grant described below and some financial offerings which we have detailed in the past. The company continues to make progress, but notes that future revenue will likely be lower than
Read at finance.yahoo.com
Ensysce Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Ensysce Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ensysce Biosciences Fundamental Analysis
We analyze Ensysce Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ensysce Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ensysce Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Ensysce Biosciences is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Ensysce Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ensysce Biosciences stock to make a market-neutral strategy. Peer analysis of Ensysce Biosciences could also be used in its relative valuation, which is a method of valuing Ensysce Biosciences by comparing valuation metrics with similar companies.
Peers
Ensysce Biosciences Related Equities
CDIO | Cardio Diagnostics | 40.74 | ||||
PHIO | Phio Pharmaceuticals | 4.81 | ||||
ATNF | 180 Life | 3.83 | ||||
ALLR | Allarity Therapeutics | 1.90 | ||||
VRAX | Virax Biolabs | 2.35 | ||||
KPRX | Kiora Pharmaceuticals | 3.57 | ||||
BDRX | Biodexa Pharmaceticals | 4.91 | ||||
SONN | Sonnet Biotherapeutics | 5.24 | ||||
QNRX | Quoin Pharmaceuticals | 6.05 | ||||
REVB | Revelation Biosciences | 6.67 | ||||
ZURA | Zura Bio | 20.86 |
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Transaction History View history of all your transactions and understand their impact on performance |